Alira Health will kick off the session with a lookback at key M&A trends from 2024, offering valuable insights into the recent landscape. Following this, a panel of private equity fund managers and executives from PE-backed CDMO platforms will discuss private equity buy-and-build strategies in the medtech CDMO industry.
This session will provide a comprehensive view of the past year's developments and 2025 opportunities in the sector.